| Recruiting | Organoids From Breast Cancer Patients Treated With Neoadjuvant Therapy NCT07260188 | Istituti Clinici Scientifici Maugeri SpA | — |
| Not Yet Recruiting | Evaluation of the RESTART Survival Programme NCT06283511 | Jules Bordet Institute | — |
| Active Not Recruiting | Patient-Derived Breast Cancer Organoids for Therapeutic Extracellular Vesicle Isolation (PDO-Mercurial01) NCT07421479 | Istituti Clinici Scientifici Maugeri SpA | — |
| Recruiting | Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy NCT06268665 | University of California, Davis | Phase 2 |
| Recruiting | Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy NCT06926543 | Dr. Tabassum Wadasadawala | Phase 3 |
| Enrolling By Invitation | Differential Expression and Potential Value of c-MYC in Non-Invasive and Invasive Mammary Carcinoma NCT06357338 | Marwa Mahmoud Hassan | — |
| Recruiting | Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer NCT06677944 | Yonsei University | Phase 2 |
| Withdrawn | Fulvestrant + Neratinib In Breast Cancer NCT04901299 | Massachusetts General Hospital | Phase 2 |
| Recruiting | TRUDI: TDXD+Durva in HER2+/Low IBC NCT05795101 | Filipa Lynce, MD | Phase 2 |
| Unknown | Development of Multi-specific Antibodies Based on Immune Microenvironment of Breast Cancer NCT05767931 | Peking University | — |
| Recruiting | (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer NCT05607004 | Atossa Therapeutics, Inc. | Phase 2 |
| Unknown | EpCAM and p53 Expressions in Infiltrating Duct Carcinoma of the Breast NCT05703815 | Sohag University | — |
| Active Not Recruiting | Onvansertib + Paclitaxel In TNBC NCT05383196 | Antonio Giordano, MD | Phase 1 / Phase 2 |
| Unknown | Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast Cancer NCT06158217 | Beijing Friendship Hospital | — |
| Recruiting | A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Recon NCT05412225 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Recruiting | Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patient NCT04677816 | Wake Forest University Health Sciences | Phase 2 |
| Recruiting | CONFIRM: Magnetic Resonance Guided Radiation Therapy NCT04368702 | Brigham and Women's Hospital | N/A |
| Active Not Recruiting | Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer. NCT05318274 | Coordinación de Investigación en Salud, Mexico | N/A |
| Active Not Recruiting | Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer NCT04648904 | Memorial Sloan Kettering Cancer Center | EARLY_Phase 1 |
| Recruiting | Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hor NCT04553770 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Active Not Recruiting | Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC NCT04448886 | Ana C Garrido-Castro, MD | Phase 2 |
| Completed | Digital Breast Tomosynthesis (DBT) to Improve Assessment of Resection Margins in Invasive Breast Cancer NCT04478669 | Aarhus University Hospital | — |
| Recruiting | Sacituzumab Govitecan In TNBC NCT04230109 | Massachusetts General Hospital | Phase 2 |
| Completed | Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous C NCT04498611 | Seoul National University Hospital | N/A |
| Unknown | Feasibility of Integrating the Outcomes4Me Smartphone Navigation Application Into the Care Management of Breas NCT04262518 | Outcomes4Me | N/A |
| Active Not Recruiting | Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer NCT04243616 | Medical College of Wisconsin | Phase 2 |
| Active Not Recruiting | Genetic Testing for All Breast Cancer Patients (GET FACTS) NCT04245176 | Dana-Farber Cancer Institute | N/A |
| Recruiting | fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases NCT06328465 | European Institute of Oncology | N/A |
| Suspended | Paclitaxel Therapeutic Drug Monitoring in Cancer Patients NCT03987555 | Wake Forest University Health Sciences | — |
| Terminated | Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Me NCT03970967 | Alpha Tau Medical LTD. | N/A |
| Completed | Examining Bioactivity of PVSRIPO in Invasive Breast Cancer NCT03564782 | Istari Oncology, Inc. | EARLY_Phase 1 |
| Unknown | MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognos NCT04004559 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Completed | Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity NCT04245150 | Case Comprehensive Cancer Center | — |
| Withdrawn | BrUOG 351: PRE-OPERATIVE APBI USING NIBB NCT03437915 | Jaroslaw Hepel | N/A |
| Unknown | Sentinel Lymph Node After Neoadjuvant Chemotherapy in Breast Carcinoma NCT03630913 | Institut Cancerologie de l'Ouest | N/A |
| Terminated | Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC NCT03361800 | UNC Lineberger Comprehensive Cancer Center | EARLY_Phase 1 |
| Completed | Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI NCT03709186 | Sunnybrook Health Sciences Centre | — |
| Active Not Recruiting | Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer NCT03595592 | Fondazione Michelangelo | Phase 3 |
| Unknown | Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoin NCT03566394 | British Columbia Cancer Agency | Phase 2 / Phase 3 |
| Active Not Recruiting | HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer NCT03387553 | H. Lee Moffitt Cancer Center and Research Institute | EARLY_Phase 1 |
| Terminated | Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer Relapse NCT03630653 | Institut Cancerologie de l'Ouest | N/A |
| Recruiting | Prospective Breast Cancer Biospecimen Collection NCT04074720 | Thomas Jefferson University | — |
| Active Not Recruiting | Olaparib In Metastatic Breast Cancer NCT03344965 | Beth Israel Deaconess Medical Center | Phase 2 |
| Completed | The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure NCT03375892 | Medical College of Wisconsin | N/A |
| Active Not Recruiting | Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions NCT02802553 | Case Comprehensive Cancer Center | N/A |
| Unknown | Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemothe NCT03381092 | Peking University | — |
| Completed | FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer NCT03212170 | University of Wisconsin, Madison | Phase 2 |
| Completed | Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer NCT03206203 | Vanderbilt-Ingram Cancer Center | Phase 2 |
| Completed | Computed Tomography (CT) Reconstruction for Axillary Lymph Node Structure NCT03247478 | Peking University | — |
| Unknown | Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Can NCT03497702 | National Cancer Center, Korea | Phase 2 |
| Completed | Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Ne NCT03219476 | Medical College of Wisconsin | Phase 2 |
| Unknown | Axillary Reverse Mapping (ARM) Technique NCT03109522 | McMaster University | N/A |
| Unknown | A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer NCT02333890 | Ottawa Hospital Research Institute | Phase 2 |
| Completed | Comparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer. NCT02773784 | Peking University | — |
| Completed | Re-Evaluation of Tumor Samples From Women With Breast Cancer With the in Vitro Diagnostic Kit "MammaTyperTM" NCT02244580 | BioNTech Diagnostics GmbH | N/A |
| Completed | AKT Inhibitor in Oestrogen Positive Breast Cancer NCT02077569 | University of Nottingham | Phase 2 |
| Terminated | Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer NCT01934335 | Ronald Weigel | Phase 2 |
| Completed | The Prone Breast Radiation Therapy Trial NCT01815476 | Toronto Sunnybrook Regional Cancer Centre | N/A |
| Completed | RNA Disruption Assay (RDA) Response Prediction in Neoadjuvant Chemotherapy Breast Cancer Treatment NCT02190227 | Jewish General Hospital | Phase 2 |
| Completed | Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receivi NCT01856543 | Memorial Sloan Kettering Cancer Center | Phase 3 |
| Unknown | Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor NCT01765049 | Seoul National University Hospital | — |
| Active Not Recruiting | Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node NCT01717131 | Institut Paoli-Calmettes | N/A |
| Completed | Breast Cancer Genome Guided Therapy Study (BEAUTY) NCT02022202 | Mayo Clinic | — |
| Unknown | Suction Drain Versus the Use of Adaptive Skin Sutures After Mastectomy ± Axillary Lymphadenectomy; a Prospecti NCT01509781 | National Institute of Oncology, Hungary | Phase 3 |
| Unknown | Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy NCT01340495 | Massachusetts General Hospital | N/A |
| Terminated | A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer NCT01194427 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Unknown | Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast Cancer NCT01597999 | Mahidol University | Phase 4 |
| Terminated | Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer NCT01138553 | University of California, San Diego | EARLY_Phase 1 |
| Completed | Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast C NCT01916837 | Jules Bordet Institute | — |
| Active Not Recruiting | Observational Study of Intra-operative Partial Irradiation of Invasive Ductal Breast Carcinomas With a Good Pr NCT04414202 | Institut du Cancer de Montpellier - Val d'Aurelle | — |
| Completed | Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Brea NCT00921115 | University of Kansas Medical Center | Phase 2 |
| Completed | Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Stagi NCT01060085 | Dartmouth-Hitchcock Medical Center | — |
| Completed | Sentinel Node Biopsy Following NeoAdjuvant Chemotherapy in Biopsy Proven Node Positive Breast Cancer NCT00909441 | Centre hospitalier de l'Université de Montréal (CHUM) | N/A |
| Completed | Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With Avastin NCT00635050 | University of Alabama at Birmingham | Phase 2 |
| Unknown | A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surge NCT00486668 | NSABP Foundation Inc | Phase 3 |
| Completed | Pre-Surgical Intervention for Targeted Therapies for Breast Cancer NCT01004744 | Columbia University | N/A |
| Completed | Axillary Lymph Node Status After Completion of Preoperative Neoadjuvant Systemic Chemotherapy in Patients NCT00507611 | Stephen Povoski | N/A |
| Completed | Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer NCT00276120 | Ohio State University Comprehensive Cancer Center | — |
| Completed | Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ NCT00581750 | Memorial Sloan Kettering Cancer Center | — |
| Completed | Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Early Breast Cancer NCT00983684 | University College, London | Phase 3 |
| Completed | Overall Diet Quality and Breast Cancer Risk NCT03304171 | University of California, Irvine | — |